Business Development
Oxcitas’ digital tools are available for partnering for:
Development of specific digital biomarkers to accompany specific pharmacological interventions
Development of multi-modal models for patient stratification and clinical outcome prediction
Oxcitas’s biological clock technologies can be combined and customised in partnership with clinical service providers to measure and predict impact of clinical interventions
A variety of commercial structures can be employed depending on the stage of the partnered program.